Sign up to save your podcasts
Or
Share Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure: the EMPEROR Program | JACC
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure: the EMPEROR Program | JACC
In this podcast, Dr. Valentin Fuster explores a study on the effects of SGLT2 inhibitors, like empagliflozin, on erythropoiesis and iron mobilization in heart failure patients. The research reveals how these drugs activate key metabolic pathways, potentially enhancing iron utilization and improving clinical outcomes, with significant implications for treatment in heart failure and chronic kidney disease.
View all episodes
By American College of Cardiology
4.2
161161 ratings
In this podcast, Dr. Valentin Fuster explores a study on the effects of SGLT2 inhibitors, like empagliflozin, on erythropoiesis and iron mobilization in heart failure patients. The research reveals how these drugs activate key metabolic pathways, potentially enhancing iron utilization and improving clinical outcomes, with significant implications for treatment in heart failure and chronic kidney disease.
More shows like JACC This Week
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
320 Listeners
JAMA Clinical Reviews
497 Listeners
This Week in Cardiology
885 Listeners
JACC Specialty Journals
18 Listeners
Circulation on the Run
31 Listeners
The Curbsiders Internal Medicine Podcast
3,343 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
140 Listeners
Core IM | Internal Medicine Podcast
1,156 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
61 Listeners
ACC CardiaCast
41 Listeners
Annals On Call Podcast
195 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
364 Listeners
Cardionerds: A Cardiology Podcast
430 Listeners
The Curious Clinicians
371 Listeners